Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Vitamin D therapy in diabetic kidney disease.

Rafieian-Kopaei M, Nasri H.

J Nephropharmacol. 2014 Jan 1;3(1):3-4. eCollection 2014. No abstract available.

2.

Antioxidant effect of angiotensin (1‑7) in the protection of pancreatic β cell function.

Zhang F, Liu C, Wang L, Cao X, Wang YY, Yang JK.

Mol Med Rep. 2016 Sep;14(3):1963-9. doi: 10.3892/mmr.2016.5514. Epub 2016 Jul 13.

3.

Pancreatic Islet Responses to Metabolic Trauma.

Burke SJ, Karlstad MD, Collier JJ.

Shock. 2016 Sep;46(3):230-8. doi: 10.1097/SHK.0000000000000607.

5.

ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice.

Shoemaker R, Yiannikouris F, Thatcher S, Cassis L.

Am J Physiol Endocrinol Metab. 2015 Oct 1;309(7):E621-31. doi: 10.1152/ajpendo.00054.2015. Epub 2015 Aug 4.

6.
7.

Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets.

Huang C, Yuan L, Cao S.

Int J Mol Med. 2015 Jul;36(1):173-85. doi: 10.3892/ijmm.2015.2207. Epub 2015 May 12.

8.

Small islets transplantation superiority to large ones: implications from islet microcirculation and revascularization.

Li W, Zhao R, Liu J, Tian M, Lu Y, He T, Cheng M, Liang K, Li X, Wang X, Sun Y, Chen L.

J Diabetes Res. 2014;2014:192093. doi: 10.1155/2014/192093. Epub 2014 Apr 16.

9.

The effect of renin angiotensin system genetic variants in acute pancreatitis.

Skipworth JR, Nijmeijer RM, van Santvoort HC, Besselink MG, Schulz HU, Kivimaki M, Kumari M, Cooper JA, Acharya J, Shankar A, Malago M, Humphries SE, Olde Damink SW, Montgomery HE.

Ann Surg. 2015 Jan;261(1):180-8. doi: 10.1097/SLA.0000000000000655.

10.

Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma.

Glenn ST, Jones CA, Sexton S, LeVea CM, Caraker SM, Hajduczok G, Gross KW.

Oncogene. 2014 Dec 11;33(50):5706-15. doi: 10.1038/onc.2013.514. Epub 2013 Dec 2.

11.

Overview of exocrine pancreatic pathobiology.

Pandiri AR.

Toxicol Pathol. 2014 Jan;42(1):207-16. doi: 10.1177/0192623313509907. Epub 2013 Nov 3. Review.

12.

High glucose activates the alternative ACE2/Ang-(1-7)/Mas and APN/Ang IV/IRAP RAS axes in pancreatic β-cells.

Härdtner C, Mörke C, Walther R, Wolke C, Lendeckel U.

Int J Mol Med. 2013 Oct;32(4):795-804. doi: 10.3892/ijmm.2013.1469. Epub 2013 Aug 14.

13.

Angiotensin converting enzyme 2: a new important player in the regulation of glycemia.

Chhabra KH, Chodavarapu H, Lazartigues E.

IUBMB Life. 2013 Sep;65(9):731-8. doi: 10.1002/iub.1190. Epub 2013 Jul 29. Review.

14.

Angiotensin-Converting Enzyme 2 Deficiency Aggravates Glucose Intolerance via Impairment of Islet Microvascular Density in Mice with High-Fat Diet.

Yuan L, Wang Y, Lu C, Li X.

J Diabetes Res. 2013;2013:405284. doi: 10.1155/2013/405284. Epub 2013 Mar 19.

15.

The renin angiotensin aldosterone system and insulin resistance in humans.

Underwood PC, Adler GK.

Curr Hypertens Rep. 2013 Feb;15(1):59-70. doi: 10.1007/s11906-012-0323-2. Review.

16.

Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice.

Takeda M, Yamamoto K, Takemura Y, Takeshita H, Hongyo K, Kawai T, Hanasaki-Yamamoto H, Oguro R, Takami Y, Tatara Y, Takeya Y, Sugimoto K, Kamide K, Ohishi M, Rakugi H.

Diabetes. 2013 Jan;62(1):223-33. doi: 10.2337/db12-0177. Epub 2012 Aug 29.

17.

Control of renin [corrected] gene expression.

Glenn ST, Jones CA, Gross KW, Pan L.

Pflugers Arch. 2013 Jan;465(1):13-21. doi: 10.1007/s00424-012-1110-2. Epub 2012 May 11. Review. Erratum in: Pflugers Arch. 2013 Jan;465(1):23.

18.

Angiotensin receptor blockade increases pancreatic insulin secretion and decreases glucose intolerance during glucose supplementation in a model of metabolic syndrome.

Rodriguez R, Viscarra JA, Minas JN, Nakano D, Nishiyama A, Ortiz RM.

Endocrinology. 2012 Apr;153(4):1684-95. doi: 10.1210/en.2011-1885. Epub 2012 Feb 21.

19.

The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome.

Putnam K, Shoemaker R, Yiannikouris F, Cassis LA.

Am J Physiol Heart Circ Physiol. 2012 Mar 15;302(6):H1219-30. doi: 10.1152/ajpheart.00796.2011. Epub 2012 Jan 6. Review.

20.

Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus.

Hayden MR, Sowers KM, Pulakat L, Joginpally T, Krueger B, Whaley-Connell A, Sowers JR.

Cardiorenal Med. 2011;1(3):193-210. Epub 2011 Jul 30.

Supplemental Content

Support Center